Infliximab Modulates Cisplatin-Induced Hepatotoxicity in Rats
Background: Cisplatin (Cis) is one of the most commonly used antineoplastic drugs. It is used as chemotherapy for many solid organ malignancies such as brain, neck, male and female urogenital, vesical and pulmonary cancers. Infliximab blocks tumor necrosis factor alpha (TNF-α). Several studies have...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2016-10-01
|
Series: | Balkan Medical Journal |
Subjects: | |
Online Access: | http://balkanmedicaljournal.org/text.php?lang=en&id=25 |